COVID-19 与肝脏：大流行六个月后我们了解多少？
COVID-19 and the liver: What do we know after six months of the pandemic?
机构信息
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico.
出版信息
Ann Hepatol. 2020 Nov-Dec;19(6):590-591. doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.
Abstract
Despite liver injury in patients infected with severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver dysfunction is mainly described in patients with severe viral disease. How liver abnormalities may affect virus infection is still unknown. Improved understanding of host genetics, lifestyle, underlying comorbidities and adequate follow-up of patients with liver damage are critical in the new scenario of the pandemic virus.
摘要
尽管感染严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）的患者存在肝损伤与住院时间延长有关，且肝功能障碍主要见于重症病毒性疾病患者，但肝异常如何影响病毒感染仍不清楚。在大流行病毒的新形势下，改善对宿主遗传、生活方式、潜在合并症以及肝损伤患者的充分随访的认识至关重要。
相似文献
1
COVID-19 and the liver: What do we know after six months of the pandemic?
Ann Hepatol. 2020 Nov-Dec;19(6):590-591. doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.
2
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.
3
Clinical insight into the involvement of gut and liver by COVID-19.
J Pak Med Assoc. 2020 Jun;70(6):952-953.
4
The liver in times of COVID-19: What hepatologists should know.
Ann Hepatol. 2020 Jul-Aug;19(4):353-358. doi: 10.1016/j.aohep.2020.05.001. Epub 2020 May 18.
5
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.
6
Management of venous thromboembolism during the COVID-19 pandemic.
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):897-898. doi: 10.1016/j.jvsv.2020.05.005. Epub 2020 May 23.
7
Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.
Gastroenterology. 2020 Sep;159(3):1137-1140.e2. doi: 10.1053/j.gastro.2020.05.010. Epub 2020 May 8.
8
Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study.
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2369-2371.e1. doi: 10.1016/j.cgh.2020.05.047. Epub 2020 May 30.
9
Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review.
Arch Iran Med. 2020 Oct 1;23(10):713-717. doi: 10.34172/aim.2020.92.
10
Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report.
Clin Pediatr (Phila). 2020 Jul;59(8):823-826. doi: 10.1177/0009922820920016. Epub 2020 Apr 15.
引用本文的文献
1
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?
Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212.
2
Long COVID: a review and proposed visualization of the complexity of long COVID.
Front Immunol. 2023 Apr 20;14:1117464. doi: 10.3389/fimmu.2023.1117464. eCollection 2023.
3
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
World J Gastroenterol. 2023 Feb 21;29(7):1123-1130. doi: 10.3748/wjg.v29.i7.1123.
4
Outcomes of COVID-19 among patients with liver disease.
World J Gastroenterol. 2023 Feb 7;29(5):815-824. doi: 10.3748/wjg.v29.i5.815.
5
It Can't Be a Coincidence: A Comparison of Cases of Autoimmune Hepatitis After Vaccination Against COVID-19.
ACG Case Rep J. 2023 Feb 1;10(1):e00965. doi: 10.14309/crj.0000000000000965. eCollection 2023 Jan.
6
Serum biomarkers for nutritional status as predictors in COVID-19 patients before and after vaccination.
J Funct Foods. 2023 Feb;101:105412. doi: 10.1016/j.jff.2023.105412. Epub 2023 Jan 10.
7
Ferritin, blood urea nitrogen, and high chest CT score determines ICU admission in COVID-19 positive UAE patients: A single center retrospective study.
PLoS One. 2022 Jul 19;17(7):e0269185. doi: 10.1371/journal.pone.0269185. eCollection 2022.
8
Spontaneous rupture of spleen in a patient with COVID-19 disease: case report and review of the literature.
J Surg Case Rep. 2022 Apr 23;2022(4):rjac124. doi: 10.1093/jscr/rjac124. eCollection 2022 Apr.
9
Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.
PLoS Pathog. 2022 Apr 21;18(4):e1010443. doi: 10.1371/journal.ppat.1010443. eCollection 2022 Apr.
10
COVID-19: Gastrointestinal manifestations, liver injury and recommendations.
World J Clin Cases. 2022 Feb 6;10(4):1140-1163. doi: 10.12998/wjcc.v10.i4.1140.
本文引用的文献
1
A systematic review and meta-analysis of the COVID-19 associated liver injury.
Ann Hepatol. 2020 Nov-Dec;19(6):627-634. doi: 10.1016/j.aohep.2020.08.064. Epub 2020 Aug 31.
2
Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review.
Obes Res Clin Pract. 2020 Sep-Oct;14(5):398-403. doi: 10.1016/j.orcp.2020.07.005. Epub 2020 Jul 23.
3
Organ-specific manifestations of COVID-19 infection.
Clin Exp Med. 2020 Nov;20(4):493-506. doi: 10.1007/s10238-020-00648-x. Epub 2020 Jul 27.
4
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.
Immunol Rev. 2020 Jul;296(1):205-219. doi: 10.1111/imr.12897. Epub 2020 Jul 13.
5
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.
PLoS One. 2020 Jun 23;15(6):e0234765. doi: 10.1371/journal.pone.0234765. eCollection 2020.
6
Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology.
Ann Hepatol. 2020 Jul-Aug;19(4):339-340. doi: 10.1016/j.aohep.2020.05.002. Epub 2020 May 23.
7
The liver in times of COVID-19: What hepatologists should know.
Ann Hepatol. 2020 Jul-Aug;19(4):353-358. doi: 10.1016/j.aohep.2020.05.001. Epub 2020 May 18.
8
Potential implications of COVID-19 in non-alcoholic fatty liver disease.
Liver Int. 2020 Oct;40(10):2568. doi: 10.1111/liv.14484. Epub 2020 May 25.
9
Liver injury in COVID-19: management and challenges.
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
10
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
Zotero 插件